EZH2 as a potential therapeutic target for gastrointestinal cancers

Autor: Hashemi, Mehrdad, Nazdari, Naghmeh, Gholamiyan, Ghazaleh, Paskeh, Mahshid Deldar Abad, Jafari, Ali Moghadas, Nemati, Fateme, Khodaei, Elaheh, Abyari, Ghazal, behdadfar, Nazanin, Raei, Behnaz, Raesi, Rasoul, Nabavi, Noushin, Hu, Peng, Rashidi, Mohsen, Taheriazam, Afshin, Entezari, Maliheh

Publikováno v: In Pathology - Research and Practice January 2024 253

Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance.

Autor: Entezari M; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.; Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Deldar Abad Paskeh M; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.; Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Orouei S; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.; Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran., Kakavand A; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Rezaei S; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Sadat Hejazi E; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Pashootan P; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Nazdari N; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Tavakolpournegari A; Group of Mutagenesis, Department of Genetics and Microbiology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain., Hashemi M; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.; Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Salimimoghadam S; Department of Biochemistry and Molecular Biology, Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Ahvaz, Iran., Mirzaei S; Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran., Taheriazam A; Farhikhtegan Medical Convergence sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.; Department of Orthopedics, Faculty of medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran., Samarghandian S; Healthy Ageing Research Centre, Neyshabur University of Medical Sciences, Neyshabur, Iran.

Publikováno v: Current cancer drug targets [Curr Cancer Drug Targets] 2023 Apr 13. Date of Electronic Publication: 2023 Apr 13.